Assessing the Response of a Sample of Iraqi Asthmatic Patients to Different Medication Regimens

Authors

  • Ali L. Jasim1 , Eman S. Saleh2 , Mustafa N. Abd Ali3

DOI:

https://doi.org/10.37506/mlu.v20i3.1552

Keywords:

Persistent asthma, Medication regimens, Tiotropium

Abstract

Asthma is a chronic inflammatory disease of respiratory airways characterized by distinctive history of

respiratory symptoms due to variable airflow obstruction which reverses either spontaneously or in response

to certain medications. Acetylcholine is a parasympathetic neurotransmitter which plays fundamental roles

in the development of persistent asthma. Treatment guidelines recommend using medium doses of inhaled

corticosteroids in addition to another controller bronchodilator instead of using high doses inhaled steroid

alone for treatment of moderate to severe persistent asthma. The inhaled long acting muscarinic antagonist,

tiotropium, was approved recently to control unresponsive asthma to inhaled corticosteroid with or without

a long acting ?-2 agonist. The aim of this study was to assess and compare the responses of a sample of Iraqi

asthmatic patients to three different medication regimens.

Author Biography

Ali L. Jasim1 , Eman S. Saleh2 , Mustafa N. Abd Ali3

1 Lecturer, Department of Clinical Pharmacy, College of Pharmacy, University of Baghdad, Baghdad, Iraq,

2 Assistant Professor, Department of Clinical Laboratory Science, College of Pharmacy, University of Baghdad,

Baghdad, Iraq, 3Assistant Professor, Department of Medicine, Baghdad College of Medicine, University of

Baghdad, Baghdad, Iraq

Published

2020-07-24

How to Cite

Ali L. Jasim1 , Eman S. Saleh2 , Mustafa N. Abd Ali3. (2020). Assessing the Response of a Sample of Iraqi Asthmatic Patients to Different Medication Regimens. Medico Legal Update, 20(3), 1119-1126. https://doi.org/10.37506/mlu.v20i3.1552